Sam Chun Dang Pharm. Co. Ltd (000250) — Capital Reinvestment Ratio
Sam Chun Dang Pharm. Co. Ltd (000250) has a Capital Reinvestment Ratio of 8.14x as of March 2025, meaning it reinvests 8% of its operating cash flow (₩1.23 Billion) in capital expenditures (₩9.97 Billion). See 000250 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sam Chun Dang Pharm. Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Sam Chun Dang Pharm. Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Check total reinvestment intensity of Sam Chun Dang Pharm. Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sam Chun Dang Pharm. Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Sam Chun Dang Pharm. Co. Ltd from 2012 to 2024. For live market cap and broader valuation context, see Sam Chun Dang Pharm. Co. Ltd (000250) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.90x | ₩21.77 Billion | ₩41.30 Billion | ▲ +102.3% |
| 2023 | 0.94x | ₩23.43 Billion | ₩21.97 Billion | ▼ -73.2% |
| 2022 | 3.51x | ₩13.28 Billion | ₩46.55 Billion | ▲ +31.3% |
| 2020 | 2.67x | ₩3.25 Billion | ₩8.68 Billion | ▲ +1139.4% |
| 2019 | 0.22x | ₩30.60 Billion | ₩6.59 Billion | ▼ -53.3% |
| 2018 | 0.46x | ₩25.03 Billion | ₩11.55 Billion | ▲ +270.1% |
| 2017 | 0.12x | ₩26.09 Billion | ₩3.25 Billion | ▼ -75.7% |
| 2016 | 0.51x | ₩17.76 Billion | ₩9.11 Billion | ▼ -19.0% |
| 2015 | 0.63x | ₩17.34 Billion | ₩10.97 Billion | ▲ +41.9% |
| 2014 | 0.45x | ₩19.55 Billion | ₩8.72 Billion | ▲ +65.9% |
| 2013 | 0.27x | ₩15.94 Billion | ₩4.28 Billion | ▼ -84.9% |
| 2012 | 1.79x | ₩1.60 Billion | ₩2.86 Billion | — |